Results 251 to 260 of about 181,087 (306)

Associations Between Pre-Existing Autoimmunity and Chimeric Antigen Receptor T Cell Therapy Toxicity for Cancer Treatment. [PDF]

ACR Open Rheumatol
Challener GJ, Wang C, Gritsch D, Usiskin IM, Walton ZE, Kohler MJ, Choi H, Sparks JA.   +7 more
europepmc   +1 more source

Recent Advances in Bioconjugation of Aromatic Amino Acid Residues by a Reactivity‐Guided Approach

The Chemical Record, EarlyView.
This review highlights recent advances in the bioconjugation of aromatic amino acids residues, focusing on strategies that leverage their inherent chemical reactivity to enable precise and versatile modifications of biomacromolecules, illustrating relevant applications.
Bruno M. da S. Santos, Lívia C. R. M. da Frota, Thais G. Silva, Fernanda G. Finelli   +3 more
wiley   +1 more source

Chimeric antigen receptor T-cell therapy for stiff-person syndrome: bridging innovation and clinical challenges in neuroimmunology. [PDF]

Ther Adv Neurol Disord
Wickel J, Motte J, Ayzenberg I, Vlad B, Gold R, Geis C, Faissner S.   +6 more
europepmc   +1 more source

Peripheral T cell lymphoma following CD19-targeted chimeric antigen receptor T cell therapy. [PDF]

Int J Hematol
Tatetsu H, Kato K, Wada A, Hirano T, Ueno S, Miyasato Y, Yamada A, Shichijo T, Higuchi Y, Ueda Y, Nosaka K, Mikami Y, Karube K, Matsuoka M, Yasunaga JI.   +14 more
europepmc   +1 more source

New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma. [PDF]

Blood Adv
Greenbaum U, Hashmi H, Elsawy M, Kim S, Moskop A, Oloyede T, Awan FT, Bachanova V, Badar T, Bar M, Barba P, Beitinjaneh AM, Cashen A, Dholaria B, Farooq U, Foglesong J, Ganguly S, Hematti P, Hill LC, Jain MD, Jain T, Kebriaei P, Kittai AS, Locke FL, Lulla PD, McGuirk JP, Mead E, Mussetti A, Nishihori T, Olson AL, Pennisi M, Perales MA, Geethakumari PR, Riedell PA, Saber W, Shouval R, Shpall EJ, Magalhaes-Silverman M, Strouse C, Turtle CJ, Vallurupalli A, Wudhikarn K, Pasquini MC, Ahmed S, Sorror M.   +44 more
europepmc   +1 more source

Chimeric Antigen Receptor Immunotherapy for Infectious Diseases: Current Advances and Future Perspectives. [PDF]

Pathogens
Kourti M, Evangelidis P, Roilides E, Iosifidis E.   +3 more
europepmc   +1 more source

m6A-Modified Nucleotide Bases Improve Translation of In Vitro-Transcribed Chimeric Antigen Receptor (CAR) mRNA in T Cells. [PDF]

Int J Mol Sci
Lao N, Li S, Ainciburu M, Barron N.
europepmc   +1 more source

Chimeric antigen receptor (CAR) -T cell therapy treatment Richter's transformation. [PDF]

Front Oncol
Feng S, Zheng P, Liu H, Sun M, Guo Y, Ma L, Liu R, Fu Z, Yang F, Ke X, Hu K.   +10 more
europepmc   +1 more source